About Index Trending news
Analyze
Pricing
SteadyMed Therapeutics

SteadyMed Therapeutics

Work at SteadyMed Therapeutics? Add yourself to this profile

SteadyMed Therapeutics

SteadyMed aspires to redefine the parenteral therapeutics experience for patients dependent upon large doses of intravenous and subcutaneous medications.
Edit Profile
More info

Elsewhere

Contributors to this profile

Companies in the same industry

Polestar Nutraceuticals Polestar Nutraceuticals Miramar Labs Miramar Labs Coronado Biosciences Coronado Biosciences MedTel.com MedTel.com Syntimmune Syntimmune Credence MedSystems Credence MedSystems EnBiotix, Inc. EnBiotix, Inc. Viventia Bio Inc. Viventia Bio Inc. Equilume Equilume TrialReach TrialReach

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 6
Add info
Latest funding Show all
Post-IPO equity
$30,000,000
Adage Capital Management, OrbiMed, Deerfield Capital Management, +3
Post-IPO equity
$32,000,000
OrbiMed, Deerfield Capital Management, Federated Investors
Employees

Team size

10+
Locations
HQ
Israel
Headquarters
$30,000,000 Post-IPO equity
Drug Delivery Business , NoCamels

SteadyMed raises $30m for Trevyent commercial launch

SteadyMed Therapeutics
SteadyMed Therapeutics